gilead hiv drug meets main goal of trial
gilead sciences inc said on wednesday that its experimental hiv drug elvitegravir met the main goal of a late-stage clinical trial.
http://feeds.reuters.com/~r/reuters/healthnews/~3/xiw_ohk_v-y/us-gilead-idustre72m3nr20110323
26963
23 Mar 2011 14:16:01
reuters
health